Extended-release metformin tablets recalled due to dangerous levels of NDMA
Marksans Pharma Limited, based out of India, is recalling their 500 mg and 750 mg metformin tablets sold under the brand name Time-Cap Labs, Inc. The recalled medication was found to contain dangerous levels of the suspected cancer-causing human carcinogen N-Nitrosodimethylamine (NDMA). These types of medications are used to treat…
RIOMET ER joins list of recalled metformin drugs due to NDMA
It’s September 23, 2020 and another metformin drug has been recalled due to unsafe levels of N-Nitrosodimethylamine (NDMA). Sun Pharmaceutical Industries, Inc. has issued a voluntary recall of their RIOMET ER 500 mg per 5 mL metformin. So far, no illnesses have been reported.
Add Bayshore Pharmaceuticals to the list of recalled diabetes drug companies due to NDMA
Bayshore Pharmaceuticals is the sixth metformin manufacturer to issue a recall due to a possible NDMA contamination. The recalled products were manufactured in Bangladesh in June of 2019, and distributed across the United States. If you've purchased any of the recalled medications, you should return them to your retailer or…
The FDA has officially recalled Zantac as well as other ranitidine drugs
We’ve posted more than a handful of stories over the last year or so about the U.S. Food and Drug Administration’s concerns over the use of ranitidine drugs, but this one is different. After numerous close calls, the FDA has finally recalled Zantac, the prescription and over-the-counter medication used to…
Diabetes drug Metformin tests negative for NDMA, will not be recalled by FDA
With all of the medication recalls lately, it would have been wise for diabetic patients to wonder if their prescribed drug was next. Well the U.S. Food and Drug Administration actually released some good news this week, there are currently “no plans to recall any Metformin products.”
Heartburn medication recalls continue, generic versions of Zantac included
Just when you think it’s safe to resume using your favorite name brand or generic heartburn medication, the U. S. Food and Drug Administration announces a new round of recalls. Once again, generic versions of Zantac are being recalled due to the presence of a “probable human carcinogen”. You shouldn’t…
FDA investigating diabetes drug ‘Metaformin’ over NDMA concerns
Stop us if you’ve heard this one before, there’s a concern over a carcinogen’s possible presence in a widely used medication. The only difference, this one has yet to be recalled, as the U.S. Food and Drug Administration is still investigating.
Despite the recall, the FDA wants consumers to know Zantac is relatively safe
Over the last few months, there have been numerous U.S. Food and Drug Administration recalls due to carcinogen concerns in heartburn medications. We’ve written about each of them here at TFF, and even posted an article just a couple weeks ago providing consumers with what the FDA considers “safe alternatives”…
Amid Zantac drug recall, FDA identifies “safe” heartburn drug alternatives
The popular heartburn medication Zantac has been recalled by the company and the U.S. Food and Drug Administration over N-Nitrosodimethylamine (NDMA) concerns. The recall began in the United States, and has reached Canada, Asia, and Europe. Initially, even the generic alternatives to Zantac were thought to be tainted, but it…
Dr. Reddy’s heartburn drug recalled over NDMA concerns
Dr. Reddy’s has joined the growing list of companies issuing a recall of heartburn medications. This week, Dr. Reddy’s Laboratories Ltd. and the U.S. Food and Drug Administration announced a recall of their “ranitidine medicines used to treat heartburn” after they were found to contain the carcinogen N-Nitrosodimethylamine aka NDMA.